StockData
McKesson Corp logo

McKesson Corp (MCK) stock

MCKNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends March 31
Financials through Q2 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 16/3026% above fair value
$1102.81+25.76 (+2.39%)

Close on Nov 13, 2026Market cap $128.58BP/E 28.4Yield 0.29%

McKesson cash

Cash and short-term investments held at the end of each period.

McKesson's cash was $6.53B at Sep 30, 2026. For fiscal 2026 it was $3.98B, down 33.3% from the year before. Over ten years it grew -2.3% a year on average. The highest annual figure on record is $6.40B in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2026Mar 31, 2026$3.98B-33.3%
FY2025Mar 31, 2025$5.96B+30.0%
FY2024Mar 31, 2024$4.58B-2.1%
FY2023Mar 31, 2023$4.68B+18.9%
FY2022Mar 31, 2022$3.94B-38.5%
FY2021Mar 31, 2021$6.40B+59.0%
FY2020Mar 31, 2020$4.02B+35.0%
FY2019Mar 31, 2019$2.98B+11.6%
FY2018Mar 31, 2018$2.67B-37.2%
FY2017Mar 31, 2017$4.25B-14.8%
FY2016Mar 31, 2016$4.99B-6.5%
FY2015Mar 31, 2015$5.34B+27.4%
FY2014Mar 31, 2014$4.19B+70.7%
FY2013Mar 31, 2013$2.46B-22.0%
FY2012Mar 31, 2012$3.15B-12.8%
FY2011Mar 31, 2011$3.61B-3.2%
FY2010Mar 31, 2010$3.73B+76.9%
FY2009Mar 31, 2009$2.11B+54.8%
FY2008Mar 31, 2008$1.36B-30.3%
FY2007Mar 31, 2007$1.95B–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2027CQ3 2026Sep 30, 2026$6.53B+63.0%
Q1 FY2027CQ2 2026Jun 30, 2026$5.16B+113.6%
Q4 FY2026CQ1 2026Mar 31, 2026$3.98B-33.3%
Q3 FY2026CQ4 2025Dec 31, 2025$2.96B+161.6%
Q2 FY2026CQ3 2025Sep 30, 2025$4.00B+59.6%
Q1 FY2026CQ2 2025Jun 30, 2025$2.42B+5.0%
Q4 FY2025CQ1 2025Mar 31, 2025$5.96B+30.0%
Q3 FY2025CQ4 2024Dec 31, 2024$1.13B-42.9%
Q2 FY2025CQ3 2024Sep 30, 2024$2.51B-0.6%
Q1 FY2025CQ2 2024Jun 30, 2024$2.30B-12.7%
Q4 FY2024CQ1 2024Mar 31, 2024$4.58B-2.1%
Q3 FY2024CQ4 2023Dec 31, 2023$1.98B-28.6%
Q2 FY2024CQ3 2023Sep 30, 2023$2.52B-13.4%
Q1 FY2024CQ2 2023Jun 30, 2023$2.64B+18.0%
Q4 FY2023CQ1 2023Mar 31, 2023$4.68B+18.9%
Q3 FY2023CQ4 2022Dec 31, 2022$2.77B+0.7%
Q2 FY2023CQ3 2022Sep 30, 2022$2.92B+35.6%
Q1 FY2023CQ2 2022Jun 30, 2022$2.23B-7.8%
Q4 FY2022CQ1 2022Mar 31, 2022$3.94B-38.5%
Q3 FY2022CQ4 2021Dec 31, 2021$2.75B-23.0%
Q2 FY2022CQ3 2021Sep 30, 2021$2.15B-30.4%
Q1 FY2022CQ2 2021Jun 30, 2021$2.42B-7.3%
Q4 FY2021CQ1 2021Mar 31, 2021$6.40B+59.0%
Q3 FY2021CQ4 2020Dec 31, 2020$3.58B+73.2%
Q2 FY2021CQ3 2020Sep 30, 2020$3.09B+127.9%
Q1 FY2021CQ2 2020Jun 30, 2020$2.61B+34.2%
Q4 FY2020CQ1 2020Mar 31, 2020$4.02B+35.0%
Q3 FY2020CQ4 2019Dec 31, 2019$2.07B+11.7%
Q2 FY2020CQ3 2019Sep 30, 2019$1.36B-36.0%
Q1 FY2020CQ2 2019Jun 30, 2019$1.95B-11.5%
Q4 FY2019CQ1 2019Mar 31, 2019$2.98B+11.6%
Q3 FY2019CQ4 2018Dec 31, 2018$1.85B-29.4%
Q2 FY2019CQ3 2018Sep 30, 2018$2.12B-17.4%
Q1 FY2019CQ2 2018Jun 30, 2018$2.20B-6.1%
Q4 FY2018CQ1 2018Mar 31, 2018$2.67B-37.2%
Q3 FY2018CQ4 2017Dec 31, 2017$2.62B+7.6%
Q2 FY2018CQ3 2017Sep 30, 2017$2.57B–
Q1 FY2018CQ2 2017Jun 30, 2017$2.34B–
Q4 FY2017CQ1 2017Mar 31, 2017$4.25B–
Q3 FY2017CQ4 2016Dec 31, 2016$2.43B–

More McKesson figures

See a number that looks wrong?